Mehrdokht Mazdeh

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Mild Cognitive Impairment

Acute Ischemic Stroke

Top Venues

Oxidative medicine and cellular longevity

Iranian journal of immunology : IJI

This page only lists publications with an associated author ORCID identifier.

Publications

Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Shirin Torkestani, Alireza Zamani, Mehrdokht Mazdeh, Elaheh Talebi Ghane, Ghodratoallah Roshanaie, Mohammad Mahdi Eftekharian
Evaluation of CD137 and CD137L Transcript Levels and the Serum sCD137 in Immune-mediated Polyneuropathy. Iranian journal of immunology : IJI 20 (1) (2023)
Shirin Torkestani, Alireza Zamani, Mehrdokht Mazdeh, Elaheh Talebi Ghane, Ghodratoallah Roshanaie, Mohammad Mahdi Eftekharian
Evaluation of CD137 and CD137L Transcript Levels and the Serum sCD137 in Immune-mediated Polyneuropathy. Iranian journal of immunology : IJI 20 (1) (2023)
Mehrdokht Mazdeh, Parnaz Abolfathi, Maryam Sabetghadam, Younes Mohammadi, Maryam Mehrpooya
Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial. Oxidative medicine and cellular longevity 2022 (2022)